Indivior posts 14% rise in quarterly profit

(Reuters) - Drugmaker Indivior Plc <INDV.L> reported a 14% rise in quarterly profit on Wednesday, as its best-selling opioid addiction drug Suboxone lost market share to generic rivals at a slower pace, than the company's previous modelling had expected.

The maker of drugs that treat opioid addiction posted http://otp.investis.com/clients/uk/indivior/rns/regulatory-story.aspx?cid=971&newsid=1318177 a pretax profit of $89 million (£73.2 million) in the second quarter ended June 30, from $78 million a year earlier.

(Reporting by Justin George Varghese in Bengaluru; Editing by Shounak Dasgupta)